Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Hemophilia B Cell Therapy: Be Bio Shuts Down Lead BE-101 Trial
Be Biopharma terminates its Phase 1/2 clinical study for hemophilia B cell therapy BE-101, reflecting strategic industry shifts away from gene programs.
Preclinical Immunology Assets: Biogen Inks $1B RayThera Acquisition
Preclinical Immunology Assets: Biogen Inks $1B RayThera Acquisition
Large B-Cell Lymphoma Clinical Trials: FDA Reviews Mosunetuzumab sBLA
The FDA accepts a supplemental biologics application for subcutaneous mosunetuzumab plus polatuzumab vedotin for relapsed/refractory LBCL.
Post GLP-1 Weight Management: Preclinical Success for Coca Leaf Extract
Magdalena Biosciences reports positive preclinical results showing a novel botanical coca leaf extract prevents weight gain following GLP-1 cessation.
Sepsis Treatment Options: New Preclinical Model Evaluates Vitamin C
Researchers at Monash University develop a highly accurate preclinical sepsis model to test sodium ascorbate, a pH-balanced form of Vitamin C.
Qihan Biotech's Universal CAR-T Therapy Wins FDA Breakthrough Status
Qihan Biotech's universal dual-target CAR-T therapy, QT-019B, secures FDA Breakthrough Therapy and RMAT designations, achieving a milestone "triple crown".
Moderna Vaccine Launch Strategy Eyes 3 Pipeline Assets & Oncology Milestones
Moderna shares climb 6% as the firm targets the launch of flu-COVID, seasonal flu, and norovirus vaccines, alongside key oncology data readouts.
Sevuparin Modulates Chronic Kidney Disease Anemia Biomarkers at EHA2026
Modus Therapeutics reports positive preclinical data on sevuparin for chronic kidney disease (CKD) anemia, highlighting synergistic effects with EPO.
Alzheimer's Disease Treatment Options: Copper Drug Restores Memory Loss
A Monash University study shows that copper compound Cu(ATSM) repairs the blood-brain barrier waste-removal system and lowers toxic amyloid-beta by 42%.
Pancreatic Cancer Research Breakthrough: Caspase-8 Triggers Tumor Death
Researchers at the University of Cologne discover a key vulnerability in KRAS-mutant pancreatic cancer cells that primes them for necroptotic cell death.
Alzheimer's Clinical Trials: First Patient Dosed with Leronlimab
CytoDyn and Weill Cornell Medicine initiate a Phase 2a clinical study, dosing the first Alzheimer's disease patient with humanized monoclonal antibody leronlimab.
FDA Expands Approval of Sanofi's Tzield for Type 1 Diabetes in Kids
Sanofi's Tzield receives an expanded FDA drug approval for children aged 8 to 17 recently diagnosed with stage 3 type 1 diabetes.
2
3
4
5
6
7
8
9
10
